Resources and Links
- Blackboard/WebCT Login
- College Catalog
- Career Series Bulletin
- Drug Information Resources
- Experiential Education
- Honors Program
- Library/Learning Resources
- P1 Orientation
- Research Opportunities for CPPS Students
- Student Affairs
- Student Organizations
- The Mentoring Collaborative
Health Science Campus
Frederic and Mary Wolfe Center
- Pharmacy Practice
- Patient Care
- Department Research
- Faculty and Staff
- Continuing Education
- Important Links
- Industrial Pharmacy
- Health Outcomes and Socioeconomic Sciences
- Department Highlights
- Department Publications
- Department Abstracts and Presentations
- Department Service Activity
- Profession Leadership
Eric G. Sahloff, Pharm.D.
Associate Professor of Clinical Pharmacy
Dr. Sahloff received his bachelors of science in pharmacy and doctor of pharmacy degrees from The University of Toledo. He
completed a specialty
residency in critical care/infectious diseases at St. Vincent Mercy Medical Center in Toledo, OH. He went on to complete a
fellowship in critical
care/infectious diseases at The University of Toledo.
Dr. Sahloff coordinates and lectures in Drug Literature Evaluation and the Seminar series, and also lectures in the Infectious Diseases and Gastrointenstinal Pharmacotherapy (PPT) courses with a focus in the area of HIV/AIDS and Hepatitis.
Dr. Sahloff actively participates in a multidisciplinary infectious diseases clinic which specializes in HIV/AIDS. Research interests include pharmacokinetic/pharmacodynamics of antiretroviral agents and HIV/AIDS pharmacotherapy.
Dr. Sahloff is currently a member of the American Association of Colleges of Pharmacy, American Society of Microbiology, and Society of Infectious Diseases Pharmacists. Dr. Sahloff is credentialled as an HIV Expert by the American Academy of HIV Medicine.
Peeters MJ, Sahloff EG, Stone G. Reliability and validity in performance-based evaluation: a 2-year experience in PharmD oral presentations using multiple faculty evaluators and a standardized rubric. Am J Pharm Ed, 2010;74:Article 171. http://www.ajpe.org/aj7409/aj7409171/aj7409171.pdf
Pinto S, Sahloff EG, Ramasamy A. Evaluating the validity and reliability of a modified survey to assess patient satisfaction with mail-order and community pharmacy settings. J Pharm Pract 2009. Published online: http://jpp.sagepub.com/cgi/rapidpdf/0897190009334329v1
Yost R, Pasquale TR, Sahloff EG. Maraviroc: the first approved CCR5-antagonist for the management of HIV-infection. Am J Health Syst Pharm 2009;66: 715-726.
Bhumbra N, Sahloff EG, Oehrtman S, Horner J. Exogenous Cushings syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir. Ann Pharmacother 2007; 41:1306-09. DOI 10.1345/aph.1K075.
Sahloff EG, Duggan JM. Clinical outcomes associated with concomitant use of atazanavir and proton-pump inhibitors. Ann Pharmacother 2006; 40:1731-36.
Duggan JM, Sahloff EG, Moudgal VV. Use of highly active antiretroviral therapy in patients with renal insufficiency. Pharmacotherapy 2005;25:698-708.
Sahloff EG. Current issues in the development of a vaccine to prevent human immunodeficiency virus: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2005;25:741-747.